v3.26.1
Condensed Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance (in shares) at Dec. 31, 2024   22,059,697    
Balance at Dec. 31, 2024 $ 62,593 $ 2 $ 199,460 $ (136,869)
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options (in shares)   10,620    
Exercise of stock options 29   29  
Issuance of common stock under stock incentive plans (in shares)   281,828    
Stock-based compensation expense 1,577   1,577  
Net Loss (1,166)     (1,166)
Balance (in shares) at Mar. 31, 2025   22,352,145    
Balance at Mar. 31, 2025 63,033 $ 2 201,066 (138,035)
Balance (in shares) at Dec. 31, 2024   22,059,697    
Balance at Dec. 31, 2024 62,593 $ 2 199,460 (136,869)
Increase (Decrease) in Stockholders' Equity        
Net Loss (1,836)      
Balance (in shares) at Jun. 30, 2025   22,570,591    
Balance at Jun. 30, 2025 64,075 $ 2 202,778 (138,705)
Balance (in shares) at Mar. 31, 2025   22,352,145    
Balance at Mar. 31, 2025 63,033 $ 2 201,066 (138,035)
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options (in shares)   12,733    
Exercise of stock options 39   39  
Issuance of common stock under stock incentive plans (in shares)   205,713    
Issuance of common stock under stock incentive plans 254   254  
Stock-based compensation expense 1,419   1,419  
Net Loss (670)     (670)
Balance (in shares) at Jun. 30, 2025   22,570,591    
Balance at Jun. 30, 2025 64,075 $ 2 202,778 (138,705)
Balance (in shares) at Dec. 31, 2025   22,977,797    
Balance at Dec. 31, 2025 68,917 $ 2 206,370 (137,455)
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options (in shares)   57,027    
Exercise of stock options 326   326  
Issuance of common stock under stock incentive plans (in shares)   286,154    
Stock-based compensation expense 1,300   1,300  
Other (2)     (2)
Net Loss (296)     (296)
Balance (in shares) at Mar. 31, 2026   23,320,978    
Balance at Mar. 31, 2026 70,245 $ 2 207,996 (137,753)
Balance (in shares) at Dec. 31, 2025   22,977,797    
Balance at Dec. 31, 2025 $ 68,917 $ 2 206,370 (137,455)
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options (in shares) 820,158      
Net Loss $ (3,885)      
Balance (in shares) at Jun. 30, 2026   24,271,438    
Balance at Jun. 30, 2026 73,107 $ 2 214,447 (141,342)
Balance (in shares) at Mar. 31, 2026   23,320,978    
Balance at Mar. 31, 2026 70,245 $ 2 207,996 (137,753)
Increase (Decrease) in Stockholders' Equity        
Exercise of stock options (in shares)   763,131    
Exercise of stock options 4,787   4,787  
Issuance of common stock under stock incentive plans (in shares)   187,329    
Issuance of common stock under stock incentive plans 290   290  
Stock-based compensation expense 1,374   1,374  
Net Loss (3,589)     (3,589)
Balance (in shares) at Jun. 30, 2026   24,271,438    
Balance at Jun. 30, 2026 $ 73,107 $ 2 $ 214,447 $ (141,342)